Objectives {#sec1-1}
==========

Orthodontic tooth movement following application of force features remodeling changes in the periodontal and dental tissues. The release of metabolites and molecules produces cellular responses surrounding the teeth which creates an environment that is suitable for tissue resorption and deposition.\[[@ref1]\] Biomarkers are substances that are measured and assessed as a marker of normal biological process, pharmacological responses, or pathological processes to a therapeutic intervention.\[[@ref2]\] An excellent biomarker is one that has the capability of describing the biological condition with regard to periodontal tissue variations and connections with orthodontic tooth movement phases, be specific and sensitive to changes.\[[@ref3]\]

Saliva is clinically informative for prognosis, clinical or laboratory diagnosis and assessment of patients with oral and systemic diseases. Most biomarkers that are present in blood, urine and gingival crevicular fluid (GCF) are also present in the saliva. Saliva collection is non-invasive as compared to drawing of blood.\[[@ref4]\]

Saliva has shown to be able to detect biomarkers such as prostaglandin E~2~ (PGE~2~) and interleukin-1β (IL-1β).\[[@ref5][@ref6]\] IL-1β, a pleiotropic cytokine of the interleukin group, has a role in bone metabolism, suppressing bone formation, inciting bone resorption, and takes part in inflammatory process.\[[@ref7]\] It is said to be the earliest marker of bone resorption during orthodontic tooth movement followed by PGE~2~.\[[@ref8][@ref9]\] PGE~2~, a derivative of the arachidonic acid cascade, increases bone resorption by stimulation of osteoclast formation, chemotactic properties, and vascular permeability by vasodilation.\[[@ref7]\]

A deterrent to orthodontic treatment is the experience of orthodontic pain.\[[@ref10]\] Pain is one of the dislikes during treatment and among the fears prior to the orthodontic treatment initiation.\[[@ref11]\] It has been shown that treatment procedures such as separator placement, orthopedic force application, archwire placement, and debonding produce pain in orthodontic patients.\[[@ref10]\]

Thus, this research was conducted to identify and estimate of PGE~2~ and IL-1β levels in saliva during initial orthodontic treatment among children and adults. This study also aimed to correlate the PGE~2~ and IL-1β values for the different age groups during initial orthodontic treatment. Apart from that, a comparison of pain intensity between different age groups and the correlation between the intensity of pain and PGE~2~ and IL-1β levels are to be investigated.

Materials and Methods {#sec1-2}
=====================

This was prospective research on 20 healthy patients requiring routine visits for orthodontic treatment in the Department of Orthodontics and Dentofacial Orthopaedics. Twenty patients were divided into a juvenile group aged 12 to 18 years and an adult group with ages above 18 years. Twenty patients were distributed equally in sex with 10 males and 10 females chosen in the study. The sample size was estimated using a power analysis. With an alpha error of 5% and power of 80%, a sample size of 10 for each gender group was adequate for detect the concentrations of IL-1β and PGE2. The Institutional Review Board provided ethical clearance for the study and the patients\' consent were taken prior to conducting the study. The inclusion criteria for the patients were (a) healthy patients (both genders) in the group of 12 to 18 years and group of 18 years and above; (b) requiring fixed orthodontic treatment regardless of the type of malocclusion; (c) good oral hygiene; (d) without any systemic diseases; and (e) without any periodontal diseases. Patients with (a) poor oral hygiene; (b) systemic diseases such as hormonal imbalances and bone diseases; (c) periodontal diseases; (d) xerostomia; (e) history of medication during treatment; (f) tobacco related habits such as smoking, tobacco chewing, etc.; and (g) oral pre-malignant lesions were excluded. As for the ethical approval from the SDM Institutional Ethics Committee, the committee had approved the research and was allotted with an ethical clearance number IRB. No. 2016/P/ORTH/37 on 4/11/2016.

All patients were treated with MBT prescription pre-adjusted edgewise brackets (3M Gemini brackets; 3M Unitek Corporation, Monrovia, Calif) with 0.022-inch slots. A passive drool method to obtain unstimulated whole saliva was taken at 4 time periods giving at total of 80 samples from 20 patients for each biomarker. The saliva was collected in a 45 ml sterile plastic tube. The saliva was collected at time intervals of (a) T~0~-- Prior to fixed orthodontic appliance placement; (b) T~1~-- 1 hour after the placement of the appliance with 0.014-inch nickel-titanium archwire (Ortho Organizers Inc., United States of America); (c) T~2~-- 1 month after the first visit; and (d) T~3~-- 1 hour after the placement of 0.016-inch nickel-titanium archwire (Ortho Organizers Inc., United States of America).

Collected saliva was transferred into 2ml Eppendorf tubes and stored in a deep freezer at --79°C. The saliva samples were then assessed for the IL-1β and PGE~2~ levels using enzyme-linked immunosorbent assay (ELISA). Commercially available IL-1β ELISA kit (Krishgen Biosystems, India) and PGE~2~ ELISA kit (KinesisDx, United States of America) were used in this study and the IL-1β and PGE~2~ concentrations (pg/mL) were calculated using a spectrophotometric microplate reader (Lisa Plus, India). The pain intensity at time intervals T~1~, T~2,~ and T~3~ were assessed using a numerical rating scale which ranges from 0 to 10. The patients were instructed to use the numerical rating scale reflect the intensity of pain felt.

The sample size was estimated using a power analysis. Data analysis was carried out using the software, Statistical Package for Social Sciences (SPSS) version 20.0. The mean and standard deviations of the concentrations of IL-1β and PGE~2~ of each group were calculated. Two-way Analysis of Variance (ANOVA) was used to compare the IL-1β and PGE~2~ and the time intervals among the gender and age groups. Tukey\'s multiple post-hoc procedures were done following the two-way ANOVA for pairwise comparisons. The percentage of changes of the IL-1β and PGE~2~ levels in each group at different time intervals were also calculated. A comparison of IL-1β and PGE~2~ values at different time points between children and adults of the same gender groups were carried out using paired *t*-tests. Pearson correlation coefficient was used to study the correlation between IL-1β and PGE~2~ values among each group. Mann-Whitney U test was carried out to compare pain scores at different time points between adults and children. The correlations between the pain and the levels of the biomarkers, IL-1β and PGE~2~, at different time points were assessed using Spearman\'s rank correlation coefficient. The significance level was set at *P* \< 0.05.

Results {#sec1-3}
=======

The mean and standard deviations of PGE~2~ and IL-1β results of each group are shown in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"} respectively. There were significant differences between gender groups and age groups with respect to PGE~2~ and IL-1β results respectively at different time points. In the PGE~2~ levels, significant differences between the male children and male adults and between male adults and female adults were seen. In the IL-1β levels, significant differences between male adults and female adults and between female children and female adults were seen. Significant differences between male children and male adults were seen at T~1~, T~2,~ and T~3~. The changes in the percentage of the PGE~2~ and IL-1β levels between the time intervals are shown in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, respectively.

###### 

Comparison of gender and age groups with respect to PGE~2~ results at different time points by two-way ANOVA, pairwise comparisons by Tukey's multiple post-hoc procedures and changes in percentage of PGE~2~ levels at different time intervals

  Comparison of Gender and Age Groups with Respect to PGE~2~ Results at Different Time Points by Two-Way ANOVA                                                                                                             
  -------------------------------------------------------------------------------------------------------------- ----------------- ----------------- ----------------- -------------- ---------- -------- ------- -------- --------
  Male child                                                                                                     5                 53.46             15.87             134.62         26.06      96.22    12.70   110.42   10.83
  Male adult                                                                                                     5                 223.08            131.05            291.68         146.24     187.18   97.54   219.48   113.30
  Female child                                                                                                   5                 41.54             9.85              69.90          13.17      43.18    5.73    51.36    5.16
  Female adult                                                                                                   5                 54.12             10.55             90.36          11.15      55.52    14.72   68.24    14.55
  Between genders                                                                                                *F*               9.2769            15.8248           17.1867        16.7624                              
  *P*                                                                                                            0.0077\*          0.0011\*          0.0008\*          0.0008\*                                            
  Between age groups                                                                                             *F*               9.4128            7.0459            5.3760         6.0115                               
                                                                                                                 *P*               0.0074\*          0.0173\*          0.0340\*       0.0261\*                             
                                                                                                                                                                                                                           
  **Pairwise Comparisons by Tukey's Multiple Post-Hoc Procedures**                                                                                                                                                         
                                                                                                                                                                                                                           
  Male child vs Male adult                                                                                       *P*=0.0048\*      *P*=0.0203\*      *P*=0.0476\*      *P*=0.0381\*                                        
  Male child vs Female child                                                                                     *P*=0.9918        *P*=0.5356        *P*=0.3638        *P*=0.3928                                          
  Male adult vs Female adult                                                                                     *P*=0.0050\*      *P*=0.0032\*      *P*=0.0037\*      *P*=0.0038\*                                        
  Female child vs Female adult                                                                                   *P*=0.9904        *P*=0.9720        *P*=0.9790        *P*=0.9657                                          
                                                                                                                                                                                                                           
  **Changes in Percentage of PGE~2~ Levels at Different Time Intervals**                                                                                                                                                   
                                                                                                                                                                                                                           
                                                                                                                 **T~0~ - T~1~**   **T~1~ - T~2~**   **T~2~ - T~3~**                                                       
                                                                                                                                                                                                                           
  Male Child                                                                                                     151.81%           -28.52%           14.76%                                                                
  Female Child                                                                                                   68.27%            -38.23%           18.94%                                                                
  Male Adult                                                                                                     25.14%            -35.83%           17.26%                                                                
  Female Adult                                                                                                   66.96%            -38.56%           22.91%                                                                

\**P*\<0.05

###### 

Comparison of gender and age groups with respect to IL-1β results at different time points by two-way ANOVA, pairwise comparisons by Tukey's multiple post-hoc procedures and changes in percentage of IL-1β levels at different time intervals

  Comparison of Gender and Age Groups with Respect to IL-1β Results at Different Time Points by Two-Way ANOVA                                                                                                          
  ------------------------------------------------------------------------------------------------------------- ----------------- ----------------- ----------------- -------------- ---------- ------- ------ ------- ------
  Male child                                                                                                    5                 4.06              2.21              11.26          3.13       5.14    0.88   7.10    1.00
  Male adult                                                                                                    5                 4.55              0.94              18.18          3.35       7.98    1.20   10.44   1.29
  Female child                                                                                                  5                 3.62              1.03              12.14          2.86       6.82    1.64   8.92    1.44
  Female adult                                                                                                  5                 11.18             1.05              24.76          2.73       13.30   0.89   17.92   1.34
  Between genders                                                                                               *F*               24.1418           7.5849            43.1566        66.5103                           
  *P*                                                                                                           0.0002\*          0.0141\*          0.0001\*          0.0001\*                                         
  Between age groups                                                                                            *F*               40.8361           52.0378           76.5038        117.0990                          
                                                                                                                *P*               0.0001\*          0.0001\*          0.0001\*       0.0001\*                          
                                                                                                                                                                                                                       
  **Pairwise Comparisons by Tukey's Multiple Post-Hoc Procedures**                                                                                                                                                     
                                                                                                                                                                                                                       
  Male child vs Male adult                                                                                      *P*=0.9458        *P*=0.0114\*      *P*=0.0083\*      *P*=0.0040\*                                     
  Male child vs Female child                                                                                    *P*=0.9588        *P*=0.9668        *P*=0.1575        *P*=0.1503                                       
  Male adult vs Female adult                                                                                    *P*=0.0002\*      *P*=0.0162\*      *P*=0.0002\*      *P*=0.0002\*                                     
  Female child vs Female adult                                                                                  *P*=0.0002\*      *P*=0.0002\*      *P*=0.0002\*      *P*=0.0002\*                                     
                                                                                                                                                                                                                       
  **Changes in Percentage of IL-1β Levels at Different Time Intervals**                                                                                                                                                
                                                                                                                                                                                                                       
                                                                                                                **T~0~ - T~1~**   **T~1~ - T~2~**   **T~2~ - T~3~**                                                    
                                                                                                                                                                                                                       
  Male Child                                                                                                    177.34%           -54.35%           38.13%                                                             
  Female Child                                                                                                  235.36%           -43.82%           30.79%                                                             
  Male Adult                                                                                                    299.56%           -56.11%           30.83%                                                             
  Female Adult                                                                                                  121.47%           -46.28%           34.74%                                                             

\**P*\<0.05

Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"} showed significant differences of PGE~2~ and IL-1β results between the children and adults of the same gender at each time point respectively. Tables [5](#T5){ref-type="table"} and [6](#T6){ref-type="table"} showed insignificant correlation between the changes of PGE~2~ results from T~0~ to T~3~ with regard to the changes in IL-1β results from T~0~ to T~3~ in children and adults.

###### 

Comparison of T~0~, T~1~, T~2~, and T~3~ time points with PGE~2~ results in children and adults by paired *t*-test

  Comparison of T~0~, T~1~, T~2~, and T~3~ Time Points with PGE~2~ Results in Male Children and Male Adults by Paired *t*-test                                                                                                                         
  -------------------------------------------------------------------------------------------------------------------------------------- ----------------- ---------- ------------- ---------------- -------------- ----------------- ---------------- ----------
  Male child                                                                                                                             T~0~              53.46      15.87                                                                            
                                                                                                                                         T~1~              134.62     26.06         -81.16           13.79          -151.81           -13.1596         0.0002\*
                                                                                                                                         T~1~              134.62     26.06                                                                            
                                                                                                                                         T~2~              96.22      12.70         38.40            22.68          28.52             3.7855           0.0193\*
                                                                                                                                         T~2~              96.22      12.70                                                                            
                                                                                                                                         T~3~              110.42     10.83         -14.20           2.97           -14.76            -10.6976         0.0004\*
  Male adult                                                                                                                             T~0~              223.08     131.05                                                                           
                                                                                                                                         T~1~              291.68     146.24        -68.60           40.37          -30.75            -3.7993          0.0191\*
                                                                                                                                         T~1~              291.68     146.24                                                                           
                                                                                                                                         T~2~              187.18     97.54         104.50           59.23          35.83             3.9452           0.0169\*
                                                                                                                                         T~2~              187.18     97.54                                                                            
                                                                                                                                         T~3~              219.48     113.30        -32.30           16.05          -17.26            -4.5008          0.0108\*
                                                                                                                                                                                                                                                       
  **Comparison of T~0~, T~1~, T~2~, and T~3~ Time Points with PGE~2~ Results in Female Children and Female Adults by Paired *t*-test**                                                                                                                 
                                                                                                                                                                                                                                                       
                                                                                                                                         **Time points**   **Mean**   **Std.Dv.**   **Mean Diff.**   **SD Diff.**   **% of change**   **Paired *t***   ***P***
                                                                                                                                                                                                                                                       
  Female child                                                                                                                           T~0~              41.54      9.85                                                                             
                                                                                                                                         T~1~              69.90      13.17         -28.36           13.56          -68.27            -4.6776          0.0095\*
                                                                                                                                         T~1~              69.90      13.17                                                                            
                                                                                                                                         T~2~              43.18      5.73          26.72            13.17          38.23             4.5356           0.0105\*
                                                                                                                                         T~2~              43.18      5.73                                                                             
                                                                                                                                         T~3~              51.36      5.16          -8.18            1.81           -18.94            -10.0811         0.0005\*
  Female adult                                                                                                                           T~0~              54.12      10.55                                                                            
                                                                                                                                         T~1~              90.36      11.15         -36.24           11.85          -66.96            -6.8358          0.0024\*
                                                                                                                                         T~1~              90.36      11.15                                                                            
                                                                                                                                         T~2~              55.52      14.72         34.84            16.04          38.56             4.8573           0.0083\*
                                                                                                                                         T~2~              55.52      14.72                                                                            
                                                                                                                                         T~3~              68.24      14.55         -12.72           4.29           -22.91            -6.6286          0.0027\*

\**P*\<0.05

###### 

Comparison of T~0~, T~1~, T~2~, and T~3~ time points with IL-1β results in children and adults by paired *t*-test

  Comparison of T~0~, T~1~, T~2~, and T~3~ Time Points with IL-1β Results in Male Children and Male Adults by Paired *t*-test                                                                                                                         
  ------------------------------------------------------------------------------------------------------------------------------------- ----------------- ---------- ------------- ---------------- -------------- ----------------- ---------------- ----------
  Male child                                                                                                                            T~0~              4.06       2.21                                                                             
                                                                                                                                        T~1~              11.26      3.13          -7.20            2.25           -177.20           -7.1466          0.0020\*
                                                                                                                                        T~1~              11.26      3.13                                                                             
                                                                                                                                        T~2~              5.14       0.88          6.12             2.47           54.35             5.5467           0.0052\*
                                                                                                                                        T~2~              5.14       0.88                                                                             
                                                                                                                                        T~3~              7.10       1.00          -1.96            0.22           -38.13            -20.0042         0.0001\*
  Male adult                                                                                                                            T~0~              4.55       0.94                                                                             
                                                                                                                                        T~1~              18.18      3.35          -13.63           3.35           -299.56           -9.0994          0.0008\*
                                                                                                                                        T~1~              18.18      3.35                                                                             
                                                                                                                                        T~2~              7.98       1.20          10.20            3.24           56.11             7.0487           0.0021\*
                                                                                                                                        T~2~              7.98       1.20                                                                             
                                                                                                                                        T~3~              10.44      1.29          -2.46            0.43           -30.83            -12.8586         0.0002\*
                                                                                                                                                                                                                                                      
  **Comparison of T~0~, T~1~, T~2~, and T~3~ Time Points with IL-1β Results in Female Children and Female Adults by Paired *t*-test**                                                                                                                 
                                                                                                                                                                                                                                                      
                                                                                                                                        **Time points**   **Mean**   **Std.Dv.**   **Mean Diff.**   **SD Diff.**   **% of change**   **Paired *t***   ***P***
                                                                                                                                                                                                                                                      
  Female child                                                                                                                          T~0~              3.62       1.03                                                                             
                                                                                                                                        T~1~              12.14      2.86          -8.52            2.43           -235.36           -7.8386          0.0014\*
                                                                                                                                        T~1~              12.14      2.86                                                                             
                                                                                                                                        T~2~              6.82       1.64          5.32             1.37           43.82             8.6945           0.0010\*
                                                                                                                                        T~2~              6.82       1.64                                                                             
                                                                                                                                        T~3~              8.92       1.44          -2.10            0.27           -30.79            -17.1464         0.0001\*
  Female adult                                                                                                                          T~0~              11.18      1.05                                                                             
                                                                                                                                        T~1~              24.76      2.73          -13.58           2.61           -121.47           -11.6473         0.0003\*
                                                                                                                                        T~1~              24.76      2.73                                                                             
                                                                                                                                        T~2~              13.30      0.89          11.46            2.98           46.28             8.5858           0.0010\*
                                                                                                                                        T~2~              13.30      0.89                                                                             
                                                                                                                                        T~3~              17.92      1.34          -4.62            0.95           -34.74            -10.8473         0.0004\*

\**P*\<0.05

###### 

Correlation between changes in PGE~2~ results from T~0~ to T~3~ with changes in IL-1β results from T~0~ to T~3~ in children by Pearson correlation coefficient

  Correlation Between Changes in PGE~2~ Results from T~0~ to T~3~ with Changes in IL-1β Results from T~0~ to T~3~ in Children by Pearson Correlation Coefficient                                                        
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------- ----- -------- --------- --------- -------- -------- ---------
  T~0~-T~1~ (Male)                                                                                                                                                 *r*   0.0135                                         
                                                                                                                                                                   *P*   0.9830                                         
  T~1~-T~2~ (Male)                                                                                                                                                 *r*            -0.4761                               
                                                                                                                                                                   *P*            0.4180                                
  T~2~-T~3~ (Male)                                                                                                                                                 *r*                      -0.1576                     
                                                                                                                                                                   *P*                      0.8000                      
  T~0~-T~1~ (Female)                                                                                                                                               *r*                                0.5142            
                                                                                                                                                                   *P*                                0.3750            
  T~1~-T~2~ (Female)                                                                                                                                               *r*                                         0.5355   
                                                                                                                                                                   *P*                                         0.3520   
  T~2~-T~3~ (Female)                                                                                                                                               *r*                                                  -0.2113
                                                                                                                                                                   *P*                                                  0.7330

*P*\<0.05

###### 

Correlation between changes in PGE~2~ results from T~0~ to T~3~ with changes in IL-~1~β results from T~0~ to T~3~ in adults by Pearson correlation coefficient

  Correlation Between Changes in PGE~2~ Results from T~0~ to T~3~ with Changes in IL-1β Results from T~0~ to T~3~ in Adults by Pearson Correlation Coefficient                                                         
  -------------------------------------------------------------------------------------------------------------------------------------------------------------- ----- -------- --------- --------- --------- -------- --------
  T~0~-T~1~ (Male)                                                                                                                                               *r*   0.2740                                          
                                                                                                                                                                 *P*   0.6560                                          
  T~1~-T~2~ (Male)                                                                                                                                               *r*            -0.0969                                
                                                                                                                                                                 *P*            0.8770                                 
  T~2~-T~3~ (Male)                                                                                                                                               *r*                      -0.3278                      
                                                                                                                                                                 *P*                      0.5900                       
  T~0~-T~1~ (Female)                                                                                                                                             *r*                                -0.1121            
                                                                                                                                                                 *P*                                0.8580             
  T~1~-T~2~ (Female)                                                                                                                                             *r*                                          0.6819   
                                                                                                                                                                 *P*                                          0.2050   
  T~2~-T~3~ (Female)                                                                                                                                             *r*                                                   0.6667
                                                                                                                                                                 *P*                                                   0.2190

*P*\<0.05

[Table 7](#T7){ref-type="table"} showed no significant differences between children and adults in terms of the pain scores at different time intervals. [Table 8](#T8){ref-type="table"} showed insignificant correlation between the PGE~2~ and IL-1β levels respectively to the pain scores.

###### 

Comparison of children and adults groups with respect to pain scores at different time points by Mann-Whitney U test

  Time points   Children group   Adults group   *Z*     *P*                            
  ------------- ---------------- -------------- ------- ------ ------ ------ --------- --------
  T~1~          6.80             1.03           12.15   5.80   1.40   8.85   -1.2473   0.2123
  T~2~          2.90             0.74           12.60   2.30   0.82   8.40   -1.5875   0.1124
  T~3~          4.40             0.84           12.35   3.80   1.03   8.65   -1.3985   0.1620

*P*\<0.05

###### 

Correlations between pain scores and PGE~2~ and IL-1β levels at different time points by Spearman's rank correlation coefficient

  Correlation between PGE~2~ Levels at Different Time Points by Spearman's Rank Correlation Coefficient                                                                                  
  ---------------------------------------------------------------------------------------------------------- ----------------- ------------------ --------- ------------------ --------- --------
  T~1~                                                                                                       -0.5048           0.1367                                                    
  T~2~                                                                                                                                            -0.1711   0.6365                       
  T~3~                                                                                                                                                                         -0.4917   0.1489
                                                                                                                                                                                         
  **Correlation between IL-1β Levels at Different Time Points by Spearman's Rank Correlation Coefficient**                                                                               
                                                                                                                                                                                         
  **IL-1β levels**                                                                                           **Pain Scores**                                                             
                                                                                                                                                                                         
  **T~1~**                                                                                                   **T~2~**          **T~3~**                                                  
                                                                                                                                                                                         
  **Spearman *R***                                                                                           ***P***           **Spearman *R***   ***P***   **Spearman *R***   ***P***   
                                                                                                                                                                                         
  T~1~                                                                                                       -0.1115           0.7592                                                    
  T~2~                                                                                                                                            -0.0790   0.8284                       
  T~3~                                                                                                                                                                         0.0197    0.9570

*P*\<0.05

Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} shows the mean levels of PGE~2~ and IL-1β respectively from T~0~ to T~3~. PGE~2~ and IL-1β increased in T~1~ levels from baseline, followed by a drop at and a slight increase seen at T~3~. [Figure 3](#F3){ref-type="fig"} shows the pain scores between the adults and children in which the pain recorded was greater in children than adults at all time points.

![Comparison of gender groups with respect to PGE~2~ values at different time points](JOS-8-16-g001){#F1}

![Comparison of gender groups with respect to IL-1β values at different time points](JOS-8-16-g002){#F2}

![Comparison of children and adults groups with respect to pain scores at different time points](JOS-8-16-g003){#F3}

Discussion {#sec1-4}
==========

PGE~2~ which is an inflammatory mediator that causes vasodilation and induces the stimulation of osteoclast formation leading to the resorption of bone.\[[@ref3][@ref7]\] Shetty *et al*.\[[@ref12]\] identified that certain drugs such as ibuprofen which is a commonly used drug for pain relief can significantly inhibit the production of PGE~2~ during the initial tooth movement. The use of such medications may affect the outcome of the PGE~2~ levels in our study. Therefore, our study implemented that medications were not allowed throughout the study as an exclusion criterion.

A study by Kanzaki *et al*.\[[@ref13]\] investigated the mechanical stress effects on the osteoclastogenesis in PDL cells\' activity. It was found that the PGE~2~ levels had increased after force application. Compressive forces and exogenous application of PGE~2~ had also increased the RANKL mRNA expression. The stressed PDL cells may induce osteoclastogenesis by increasing the RANKL expression via synthesis of PGE~2~ during tooth movement.

IL-1β, a pleiotropic cytokine is said to be the earliest marker of bone resorption during tooth movement in orthodontic treatment.\[[@ref7][@ref8]\] Uematsu *et al*.\[[@ref14]\] studied IL-1β levels following force application on canines and found IL-1β levels had increased after 24 hours and is associated with resorption of bone during movement of teeth. They concluded that IL-1β regulated bone remodeling processes.

Luppanapornlap *et al*.\[[@ref15]\] investigated the force magnitudes of orthodontic treatment on the levels of IL-1β secretion, the pain intensity and amount of tooth movement in canine retraction. IL-1β was found to be increased when forces were applied and correlated with the intensity of pain. The levels were higher when greater force was applied but effective tooth movement could be achieved with lighter forces with less pain. Leethanakul *et al*.\[[@ref16]\] studied the effects of vibratory stimulus application on the secretion of IL-1β during distalization of canines. The IL-1β levels were greater at pressure sites than areas of tension. Vibratory stimulus and force application had increased the IL-1β which lead to greater bone resorption and tooth movement.

In this study, significant differences in the levels of PGE~2~ and IL-1β in all groups at T~0~-T~1~, T~1~-T~2~, and T~2~-T~3~ were seen. An increase of PGE~2~ and IL-1β at T~1~ may be caused by the acute inflammatory process that occurs during initial orthodontic treatment. This rise of IL-1β concurs with Grieve *et al*.\[[@ref17]\] and Kapoor *et al*.\[[@ref18]\] in which they found IL-1β to be increased at 1 and 24 hours, whereas the levels of PGE~2~ had increased later at 24 and 48 hours.

It was followed by drop in both PGE~2~ and IL-1β levels at T~2~. This could be associated with a force decay, lack of active force and alignment of the teeth to some degree compared to the first visit. Lee *et al*.\[[@ref19]\] and Chibebe *et al*.\[[@ref20]\] saw decreases of PGE~2~ and IL-1β in their studies after the 24-hour mark. At T~3~ in this study, there was an increase in PGE~2~ which could be attributed with a larger force applied since an archwire with a greater dimension.

The PGE~2~ in adults were higher than children of the same gender. This was contradicted by the studies of Chibebe *et al*.\[[@ref20]\] where they found that juveniles displayed greater levels of PGE~2~ as their inflammatory systems are more active leading to a faster response to changes in the local environment. However, a study by Ohzeki *et al*.\[[@ref21]\] supports that older individuals produce greater amounts of PGE~2~ whereby their study showed that the aged periodontal ligament fibroblasts were larger in size than the younger cells and produced greater amounts of PGE~2~ when forces were applied.

IL-1β levels were greatest in female adults and with female children being slightly greater than the male children group. This disagrees with the study by Vujačić *et al*.\[[@ref22]\] where they found the IL-1β levels to be greater in children as there is increased metabolic activity of the PDL in younger individuals and increased activity of periodontal cells. Giannopoulou *et al*.\[[@ref23]\] on the other hand found that the young adults undergoing fixed orthodontic treatment had higher levels of IL-1β than adolescents and children which may be associated with age-related changes, puberty, and hormones. Individual variations such as IL-1β gene polymorphism affects the amount of secretion of IL-1β when same force levels were applied as shown by a study by Iwasaki *et al*.\[[@ref24]\] All the studies related to PGE~2~ and IL-1β were done in GCF and to our knowledge, no salivary research was done in relation to these biomarkers.

Another aspect to be looked into is the effect of psychological stress during orthodontic treatment. Mirzakouchaki *et al*.\[[@ref25]\] showed that cortisol levels increased when rats were stressed leading to a reduction in monocyte numbers. The osteoclasts numbers in turn decrease as monocytes are their progenitors. Cortisol produced in stressful conditions could have also played a role in influencing the values of PGE~2~ and IL-1β in this study.

The pain intensity was found to be higher in the children group than the adults but was insignificantly different. Brown *et al*.\[[@ref26]\] found that adolescents had higher levels of pain which may be attributed by the stage of psychological development and lower psychological well-being levels. Similarly, the children group in this study had higher pain levels. In our study, we found no significant correlation between the pain scores and both PGE~2~ and IL-1β levels at the time points, T~1~, T~2,~ and T~3~. Gameiro *et al*.\[[@ref27]\] found no significant correlation between the pain experience with the IL-1β or PGE~2~ levels in GCF. Despite these mediators playing a role in investigating cellular responses to mechanical stresses, they could not be identified as the only factor involved describing the process of pain.\[[@ref28][@ref29]\]

One of the limitations of this study is that individual variations at a genetic level in each patient may influence the readings of the mediators studied. The severity of the malocclusion could also affect PGE~2~ and IL-1β levels that were produced. A larger sample size could have increased the accuracy of the results and reduce the margin of error. Further research should be conducted on how variations in each individual can affect these mediators and the complex interplay within the periodontium during tooth movement as well as the pain intensity.

Conclusion {#sec1-5}
==========

The IL-1β and PGE~2~ concentrations in the adults were higher than that of the childrenIn all the groups, PGE~2~ and IL-1β levels increased significantly on application of the first archwire at T~1~ followed with a decrease in the levels at T~2~ and a subsequent rise in these levels on placement of an archwire of larger dimension at T~3~Saliva is a non-invasive diagnostic aid to study the variation of the concentrations of PGE~2~ and IL-1β during orthodontic treatmentThe correlation between the variations of IL-1β and the variations of PGE~2~ was not significant in all the groupsPain intensity was not significant between children than adults. Insignificant correlation between the pain intensity and the biomarkers, IL-1β and PGE~2~ was noted.
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